Cargando…

Contribution of Syndecans to the Cellular Entry of SARS-CoV-2

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel emerging pathogen causing an unprecedented pandemic in 21st century medicine. Due to the significant health and economic burden of the current SARS-CoV-2 outbreak, there is a huge unmet medical need for novel interventions e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hudák, Anett, Letoha, Annamária, Szilák, László, Letoha, Tamás
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8159090/ https://www.ncbi.nlm.nih.gov/pubmed/34069441 http://dx.doi.org/10.3390/ijms22105336

Ejemplares similares

Syndecan-4 Is a Key Facilitator of the SARS-CoV-2 Delta Variant’s Superior Transmission
por: Hudák, Anett, et al.
Publicado: (2022)

Exploring the Syndecan-Mediated Cellular Internalization of the SARS-CoV-2 Omicron Variant
por: Letoha, Annamária, et al.
Publicado: (2023)

Syndecan-4 Mediates the Cellular Entry of Adeno-Associated Virus 9
por: Hudák, Anett, et al.
Publicado: (2023)

The Interplay of Apoes with Syndecans in Influencing Key Cellular Events of Amyloid Pathology
por: Hudák, Anett, et al.
Publicado: (2021)

Biodistribution and Cellular Internalization of Inactivated SARS-CoV-2 in Wild-Type Mice
por: Hudák, Anett, et al.
Publicado: (2022)

Contribution of syndecans to cellular uptake and fibrillation of α-synuclein and tau
por: Hudák, Anett, et al.
Publicado: (2019)

Syndecan-3 as a Novel Biomarker in Alzheimer’s Disease
por: Hudák, Anett, et al.
Publicado: (2022)

Contribution of syndecans to cellular internalization and fibrillation of amyloid-β(1–42)
por: Letoha, Tamás, et al.
Publicado: (2019)

The phosphomimetic mutation of syndecan-4 binds and inhibits Tiam1 modulating Rac1 activity in PDZ interaction–dependent manner
por: Keller-Pinter, Aniko, et al.
Publicado: (2017)

Reconsidering Dogmas about the Growth of Bacterial Populations
por: Ughy, Bettina, et al.
Publicado: (2023)

Umbelliferone and eriodictyol suppress the cellular entry of SARS-CoV-2
por: Cheng, Fang-Ju, et al.
Publicado: (2023)

Syndecan‐4 influences mammalian myoblast proliferation by modulating myostatin signalling and G1/S transition
por: Keller‐Pinter, Aniko, et al.
Publicado: (2018)

Pathogenesis and mutagenesis of SARS-CoV-2: cellular attachment, entry, and infection
por: Egbuna, Chukwuebuka, et al.
Publicado: (2022)

LRRC15 inhibits SARS-CoV-2 cellular entry in trans
por: Song, Jaewon, et al.
Publicado: (2022)

Receptors and Cofactors That Contribute to SARS-CoV-2 Entry: Can Skin Be an Alternative Route of Entry?
por: Barthe, Manon, et al.
Publicado: (2023)

Cell entry by SARS-CoV-2
por: Peng, Ruchao, et al.
Publicado: (2021)

Clotting and SARS-CoV-2 entry
por: Hofer, Ursula
Publicado: (2022)

Essential oils block cellular entry of SARS-CoV-2 delta variant
por: Torres Neto, Luiz, et al.
Publicado: (2022)

SARS-CoV-2 Cellular Entry Is Independent of the ACE2 Cytoplasmic Domain Signaling
por: Karthika, Thankamani, et al.
Publicado: (2021)

Closing the portal to SARS-CoV-2 cellular entry: May open newer avenues…
por: Sharma, Ridhima, et al.
Publicado: (2021)

Cell entry mechanisms of SARS-CoV-2
por: Shang, Jian, et al.
Publicado: (2020)

SARS-CoV-2, Early Entry Events
por: Chambers, James P., et al.
Publicado: (2020)

Mechanisms of SARS-CoV-2 entry into cells
por: Jackson, Cody B., et al.
Publicado: (2021)

Lipid Raft Integrity and Cellular Cholesterol Homeostasis Are Critical for SARS-CoV-2 Entry into Cells
por: Bakillah, Ahmed, et al.
Publicado: (2022)

Anti-calmodulins and Tricyclic Adjuvants in Pain Therapy Block the TRPV1 Channel
por: Oláh, Zoltán, et al.
Publicado: (2007)

Computational designing of a peptide that potentially blocks the entry of SARS-CoV, SARS-CoV-2 and MERS-CoV
por: V. K., Priya, et al.
Publicado: (2021)

Integrin mediates cell entry of the SARS-CoV-2 virus independent of cellular receptor ACE2
por: Liu, Jiamnin, et al.
Publicado: (2022)

Tumor markers as an entry for SARS‐CoV‐2 infection?
por: Xia, Pu, et al.
Publicado: (2020)

Entry, egress and vertical transmission of SARS-CoV-2
por: Zhang, Hui, et al.
Publicado: (2021)

Role of host factors in SARS-CoV-2 entry
por: Evans, John P., et al.
Publicado: (2021)

Quinolizidines as Novel SARS-CoV-2 Entry Inhibitors
por: Huang, Li, et al.
Publicado: (2022)

Roles of host proteases in the entry of SARS-CoV-2
por: Zabiegala, Alexandria, et al.
Publicado: (2023)

Syndecan-1 and FGF-2, but Not FGF Receptor-1, Share a Common Transport Route and Co-Localize with Heparanase in the Nuclei of Mesenchymal Tumor Cells
por: Zong, Fang, et al.
Publicado: (2009)

Human ACE2 Genetic Polymorphism Affecting SARS-CoV and SARS-CoV-2 Entry into Cells
por: Hattori, Takanari, et al.
Publicado: (2022)

Divalent Heavy Metal Cations Block the TRPV1 Ca(2+) Channel
por: Pecze, László, et al.
Publicado: (2012)

Capivasertib restricts SARS-CoV-2 cellular entry: a potential clinical application for COVID-19
por: Sun, Fang, et al.
Publicado: (2021)

A Retinol Derivative Inhibits SARS-CoV-2 Infection by Interrupting Spike-Mediated Cellular Entry
por: Tong, Liangqin, et al.
Publicado: (2022)

Specific Syndecan-1 Domains Regulate Mesenchymal Tumor Cell Adhesion, Motility and Migration
por: Zong, Fang, et al.
Publicado: (2011)

The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
por: Leach, D. A., et al.
Publicado: (2021)

APOE interacts with ACE2 inhibiting SARS-CoV-2 cellular entry and inflammation in COVID-19 patients
por: Zhang, Hongsheng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hhkcbcsdrdldcndqte2755kucm